The role of potassium in depth profiling of the tumor border in bone-invasive oral cancer using laser-induced breakdown spectroscopy (LIBS): a pilot study.
Bone invasion
Depth profiling
Head and neck cancer
Laser-induced breakdown spectroscopy (LIBS)
Microscopic tumor spread
Potassium
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
28
08
2023
accepted:
05
09
2023
medline:
15
11
2023
pubmed:
17
9
2023
entrez:
16
9
2023
Statut:
ppublish
Résumé
Microscopic tumor spread beyond the macroscopically visible tumor mass in bone represents a major risk in surgical oncology, where the spatial complexity of bony resection margins cannot be countered with rapid bone analysis techniques. Laser-induced breakdown spectroscopy (LIBS) has recently been introduced as a promising option for rapid bone analysis. The present study aimed to use LIBS-based depth profiling based on electrolyte disturbance tracking to evaluate the detection of microscopic tumor spread in bone. After en bloc resection, the tumor-infiltrated mandible section of a patient's segmental mandibulectomy specimen was natively investigated using LIBS. Spectral and electrolytic depth profiles were analyzed across 30 laser shots per laser spot position in healthy bone and at the tumor border. For the histological validation of the lasered positions, the mandibular section was marked with a thin separating disc. Solid calcium (Ca) from hydroxyapatite and soluble Ca from dissolved Ca can be reliably differentiated using LIBS and reflect the natural heterogeneity of healthy bone. Increased potassium (K) emission values in otherwise typically healthy bone spectra are the first spectral signs of tumorous bone invasion. LIBS-based depth profiles at the tumor border region can be used to track tumor-associated changes within the bone with shot accuracy based on the distribution of K. Depth profiling using LIBS might enable the detection of microscopic tumor spread in bone. In the future, direct electrolyte tracking using LIBS should be applied to other intraoperative challenges in surgical oncology to advance rapid bone analysis by spectroscopic-optical techniques.
Identifiants
pubmed: 37716922
doi: 10.1007/s00432-023-05411-9
pii: 10.1007/s00432-023-05411-9
pmc: PMC10645631
doi:
Substances chimiques
Potassium
RWP5GA015D
Calcium
SY7Q814VUP
Electrolytes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16635-16645Subventions
Organisme : Schäfersnolte-Gedächtnis-Stiftung Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
ID : Fonds 361717 MKG
Informations de copyright
© 2023. The Author(s).
Références
Biomed Opt Express. 2014 Oct 21;5(11):4013-23
pubmed: 25426327
J Histochem Cytochem. 2017 Dec;65(12):705-722
pubmed: 28958188
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Rev Physiol Biochem Pharmacol. 2021;181:375-427
pubmed: 32789787
Bone. 2008 Sep;43(3):621-7
pubmed: 18585993
Biochim Biophys Acta Rev Cancer. 2019 Dec;1872(2):188304
pubmed: 31348974
Nature. 2016 Sep 22;537(7621):497-499
pubmed: 27626384
Oncotarget. 2016 Jul 12;7(28):43239-43255
pubmed: 27259269
Nature. 2016 Sep 22;537(7621):539-543
pubmed: 27626381
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Oncol Rep. 2022 Apr;47(4):
pubmed: 35211756
Sci Signal. 2018 Apr 24;11(527):
pubmed: 29692361
Bioelectricity. 2019 Sep 1;1(3):188-200
pubmed: 34471821
J Biophotonics. 2017 Oct;10(10):1250-1261
pubmed: 27875030
Front Pharmacol. 2020 Feb 28;11:143
pubmed: 32184726
J Craniomaxillofac Surg. 2017 Sep;45(9):1464-1471
pubmed: 28756966
Acta Biochim Biophys Sin (Shanghai). 2019 Jun 20;51(6):562-570
pubmed: 31139826
Metabolomics. 2018;14(3):31
pubmed: 29479299
Bone. 2017 Jan;94:42-49
pubmed: 27725316
Front Oncol. 2022 Jul 07;12:836803
pubmed: 35875164
Sci Rep. 2022 Sep 30;12(1):16391
pubmed: 36180727
Oral Oncol. 2019 Mar;90:8-12
pubmed: 30846181
Oral Maxillofac Surg Clin North Am. 2017 Aug;29(3):281-292
pubmed: 28551338
Front Pharmacol. 2021 Aug 27;12:742862
pubmed: 34512366
Br J Cancer. 2017 Sep 5;117(6):867-875
pubmed: 28742795
Oncol Lett. 2022 Sep 13;24(5):382
pubmed: 36238359
Handb Exp Pharmacol. 2021;267:253-275
pubmed: 33864122
Explor Target Antitumor Ther. 2022;3(4):445-462
pubmed: 36071984
J Adv Res. 2019 Jan 26;18:1-7
pubmed: 30792922
Oral Oncol. 2023 Mar;138:106308
pubmed: 36682186
Cell Tissue Bank. 2015 Dec;16(4):569-78
pubmed: 25736401
Physiol Rev. 2018 Apr 1;98(2):559-621
pubmed: 29412049
Front Immunol. 2022 Oct 28;13:961695
pubmed: 36389709